HNGE Hinge Health, Inc.

NYSE www.hingehealth.com


$ 42.50 $ -4.44 (-9.5 %)    

Wednesday, 12-Nov-2025 19:21:52 EST
QQQ $ 619.53 $ -3.74 (-0.6 %)
DIA $ 482.77 $ 2.24 (0.47 %)
SPY $ 681.90 $ -1.55 (-0.23 %)
TLT $ 90.02 $ 0.16 (0.18 %)
GLD $ 387.00 $ 5.86 (1.54 %)
$ 42.33
$ 46.75
$ 42.01 x 200
$ 46.00 x 15
-- - --
$ 33.42 - $ 62.18
2,282,228
na
3.34B
nm
nm
TBD
na
na (nm)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-07-2025 09-30-2025 10-Q
2 08-11-2025 06-30-2025 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $61 t...

Core News & Articles

Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $62 to $65.

Core News & Articles

Piper Sandler analyst Jessica Tassan reiterates Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from ...

Core News & Articles

Hinge Health (NYSE:HNGE) raises FY2025 sales outlook from $548.000 million-$552.000 million to $572.000 million-$574.000 millio...

Core News & Articles

Hinge Health (NYSE:HNGE) sees Q4 sales of $155.000 million-$157.000 million vs $145.468 million analyst estimate.

Core News & Articles

Hinge Health (NYSE:HNGE) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.15) by...

Core News & Articles

Evercore ISI Group analyst Elizabeth Anderson maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price targ...

 trump-administration-review-targets-medical-supply-chain-vulnerabilities

The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—includ...

Core News & Articles

Morgan Stanley analyst Craig Hettenbach maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target fro...

Core News & Articles

Stifel analyst David Grossman maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $63 to $66.

Core News & Articles

Baird analyst Vikram Kesavabhotla initiates coverage on Hinge Health (NYSE:HNGE) with a Neutral rating and announces Price T...

Core News & Articles

Canaccord Genuity analyst Richard Close maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $52 t...

Core News & Articles

JMP Securities analyst Aaron Kimson maintains Hinge Health (NYSE:HNGE) with a Market Outperform and raises the price target ...

Core News & Articles

Barclays analyst Saket Kalia maintains Hinge Health (NYSE:HNGE) with a Overweight and raises the price target from $51 to $62.

Core News & Articles

Evercore ISI Group analyst Elizabeth Anderson maintains Hinge Health (NYSE:HNGE) with a Outperform and raises the price targ...

Core News & Articles

Needham analyst Ryan MacDonald maintains Hinge Health (NYSE:HNGE) with a Buy and raises the price target from $47 to $59.

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION